MedPath
HSA Approval

GRANISETRON-AFT SOLUTION FOR INJECTION 1MG/ML

SIN14612P

GRANISETRON-AFT SOLUTION FOR INJECTION 1MG/ML

GRANISETRON-AFT SOLUTION FOR INJECTION 1MG/ML

September 11, 2014

APEX PHARMA MARKETING PTE. LTD.

APEX PHARMA MARKETING PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantAPEX PHARMA MARKETING PTE. LTD.
Licence HolderAPEX PHARMA MARKETING PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, SOLUTION

INTRAVENOUS, INTRAMUSCULAR

Medical Information

A04AA02

granisetron

Manufacturer Information

APEX PHARMA MARKETING PTE. LTD.

QILU PHARMACEUTICAL CO., LTD

Active Ingredients

GRANISETRON HYDROCHLORIDE 1.12 mg EQV GRANISETRON

1 mg/ml

Granisetron

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

GRANISETRON-AFT SOLUTION FOR INJECTION 1MG/ML - HSA Approval | MedPath